Al Dera H, Habgood MD, Furness JB, Brock JA. Prominent contribution of L-type ca 2ϩ channels to cutaneous neurovascular transmission that is revealed after spinal cord injury augments vasoconstriction. Am J Physiol Heart Circ Physiol 302: H752-H762, 2012. First published November 11, 2011; doi:10.1152/ajpheart.00745.2011In patients with spinal cord injury (SCI), somatosympathetic reflexes produce exaggerated decreases in skin blood flow below the lesion. This hypoperfusion appears to result from an increased responsiveness of cutaneous arterial vessels to neural activation. Here we investigated the mechanisms that underlie SCI-induced enhancement of neurovascular transmission in a cutaneous vessel, the rat tail artery. Isometric contractions of arterial segments from T11 spinal cord transected and sham-operated rats were compared 6 wk postoperatively. SCI more than doubled the amplitudes of contractions of arteries in response to moderate frequencies of nerve stimulation (0.1 to 1 Hz). In arteries from SCI rats, but not those from sham-operated rats, the L-type Ca 2ϩ channel blocker nifedipine (1 M) reduced the amplitudes of nerve-evoked contractions. Furthermore, while the sensitivity to the agonists phenylephrine (␣1-adrenoceptor selective) and clonidine (␣2-adrenoceptor selective) did not differ significantly between arteries from SCI and sham-operated rats, nifedipine had a greater inhibitory effect on contractions to both agents in arteries from SCI rats. Although sensitivity to clonidine was unchanged, SCI selectively reduced the contribution of postjunctional ␣2-adenceptors to nerve-evoked contractions. In arteries from unoperated rats, the L-type channel agonist BAY K 8644 (0.1 M) produced a similar enhancement of nerve-evoked contraction to that produced by SCI and also selectively reduced the contribution of ␣2-adrenceptors to these responses. Together the findings demonstrate that the SCIinduced enhancement of neurovascular transmission in the rat tail artery can largely be accounted for by an increased contribution of L-type Ca 2ϩ channels to activation of the vascular smooth muscle.
vasoconstrictor neurons; vascular reactivity SEVERE SPINAL CORD INJURY (SCI) damages the brainstem-derived inputs to sympathetic preganglionic neurons that control the vasculature, and thus higher centers no longer influence the vasoconstrictor neurons located below the level of the lesion. Although SCI severs bulbospinal inputs to sympathetic preganglionic neurons, the spinal reflex pathways below the lesion remain intact and are unopposed by inhibitory inputs from the brainstem. In the absence of central modulation, reflexly evoked vasoconstriction elicited by distension of visceral organs, or by some other unheeded afferent input from caudal to the lesion, is exaggerated (21) . In SCI patients, spinal reflex-evoked vasoconstriction is most readily studied in the skin (e.g., 7, 8, 34) , where modified neural control of blood flow results in poor thermoregulation (21) and may contribute to increasing the risk of pressure sores and impair wound healing (11, 37) .
Studies (25, 40) in SCI animals have suggested that reflexly evoked vasoconstriction is aggravated by sympathetic hyperexcitability related to plasticity of connections and/or inflammation within the damaged spinal cord. However, in humans with high thoracic or cervical SCI, microneurographic recordings in cutaneous vasoconstrictor axons showed only brief bursts of activity in response to bladder compression or electrical stimulation of abdominal skin (34, 35) . These bursts were associated with reductions in skin blood flow that were prolonged relative to those in able-bodied subjects, suggesting that a more important change may be that the vasculature caudal to a spinal lesion becomes hyperresponsive to sympathetic activity (see also Ref. 7) .
In support of this suggestion, recent studies (6, 30, 43) in rats have demonstrated that chronic SCI produces a large enhancement of neurovascular transmission in arteries supplying the cutaneous and splanchnic vascular beds. As the effects of SCI in rat tail artery, which supplies blood to the skin of tail, were similar to those observed when its supplying postganglionic neurons were decentralized (by transecting their preganglionic inputs; Ref. 42) , it is likely that the decrease in ongoing sympathetic activity produced by SCI triggers the enhancement of neurovascular transmission in vessels caudal to the injury. However, the mechanisms that potentiate neurovascular transmission differ between the vessels studied. In mesenteric arteries, but not in the other vessels studied, a reduction in uptake of norepinephrine (NE) via the neuronal NE transporter contributes to the enhancement of neurovascular transmission (6) . By contrast, in tail artery, SCI increased reactivity to depolarization of the vascular muscle with a high K ϩ concentration, suggesting an increased contribution of voltage-dependent Ca 2ϩ entry to contraction (43) , but the contribution of this change to the enhancement of neurovascular transmission has not been investigated.
In the present study, we tested the hypothesis that SCI increases the contribution of L-type Ca 2ϩ channels to neurovascular transmission in the rat tail artery. We also investigated whether SCI changes the contribution of L-type Ca 2ϩ channels to ␣ 1 -and ␣ 2 -adenoceptor agonist-evoked contractions and whether this explains the changed contribution of ␣ 1 -and ␣ 2 -adrenoceptors to neurovascular transmission that has previously been observed following SCI (43) . Finally, we tested whether increasing the activity of L-type Ca 2ϩ channel activity with BAY K 8644 produced similar changes in neurovascular transmission to those produced by SCI. The findings demonstrate that the increase in neurovascular transmission produced by SCI is in large part explained by a marked increase in the contribution of L-type Ca 2ϩ channels to nerve-evoked contraction and that BAY K 8644 mimics this effect.
MATERIALS AND METHODS
The University of Melbourne Animal Experimentation Ethics Committee approved all experimental procedures. The spinal cord was transected in six male Sprague-Dawley rats (ϳ8 wk of age) that were anesthetized with isoflurane (3% in oxygen). A longitudinal incision was made through the lower thoracic skin to expose the underlying musculature and the T9-T11 vertebrae were identified. The muscles connecting to the spines of the vertebrae were detached, and a laminectomy was performed to remove the dorsal aspect of the T10 vertebrum. The spinal cord was then transected with a fine pair of scissors. This vertebral level corresponds to the T11 spinal level (14) , and the lesion severs all bulbospinal connections to the preganglionic neurons that control the tail artery, which are located in the T13-L2 spinal segments (27, 33) . The laminectomy site was closed with three layers of sutures through the adjacent vertebral musculature, the subdermal tissues, and the skin. Sterile saline (1 ml/kg) and analgesic (0.06 mg/kg buprenorphine; Reckitt Benckiser, Sydney, Australia) were administered postoperatively by intraperitoneal injection, and the animal was placed in a cage on a heated pad to recover from the anesthesia. Additional injections of saline and analgesic were administered daily for the first 4 postoperative days. Bladders were manually expressed three times daily until the animals regained the ability to empty their own bladders. The completeness of the lesion was confirmed histologically. In six age-matched sham-operated controls, the laminectomy was performed to expose the spinal cord and postoperative treatments were similar except for bladder management. The SCI and sham-operated rats were maintained for 6 wk postsurgery. To investigate the effects of stimulating L-type Ca 2ϩ channel activity with BAY K 8644, tissues from 18 unoperated male SpragueDawley rats (9 -12 wk of age) were used.
The rats were killed by inhalation of CO 2, with the concentration of CO2 being gradually increased. The tail artery was dissected from 20 -40 mm distal to the base of the tail. After isolation, the arteries were maintained in physiological saline with the following composition (in mM): 150. 
Mechanical Responses
Segments of artery (ϳ1.5 mm long) were mounted isometrically between stainless steel wires (50-m diameter) in two four-chamber myographs (Multi Myograph 610M; Danish Myo Technology). Each myograph chamber contained 6 ml of physiological saline that was exchanged at regular intervals. There was some variation in the lengths (mean: 1.6 mm; range: 1.1-2.0 mm) and lumen diameters (see RESULTS) of the artery segments studied. To normalize the basal conditions, the measured force was converted to the effective pressure exerted on the luminal surface of the artery (see Ref. 24) . At first, the effective distending pressure under basal conditions was set at 13.3 kPa (ϳ100 mmHg) and the tissues were left to equilibrate for 30 min at which time the effective distending pressure stabilized at ϳ9 kPa (ϳ 70 mmHg) and did not differ significantly between the groups of vessels. At this setting, the arteries are at the peaks of the length-tension relations (43) . The nerveand agonist-evoked contractions were measured as increases in wall tension (force/2 ϫ vessel length; see Ref. 24) .
After equilibration, all vessels were contracted with three applications of phenylephrine (PE; 3 M; Sigma Chemical, Castle Hill, NSW, Australia). The contractions to the first and second applications of PE were terminated by washout, whereas the muscarinic agonist carbachol (1 M; Sigma) was applied when the contraction to the third application of PE had plateaued to assess the vasodilator action of activating the endothelium.
Electrically evoked contractions. The artery segments were electrically stimulated with trains of stimuli (20-V, 0.2-ms pulse width) applied through platinum plate electrodes mounted either side of the tissue. In preliminary experiments, it was confirmed that these stimulus parameters were supramaximal for activating the perivascular sympathetic axons and that the contractions produced by electrical stimulation were fully blocked by tetrodotoxin (0.5 M), confirming they are mediated by action potential-evoked neurotransmitter release.
Arteries from sham-operated and SCI rats were first stimulated with single trains of 25 stimuli at 0.1, 0.3, 0.5, and 1 Hz, with each train separated by a 4-min interval. These frequencies of stimuli were chosen because they are similar to the frequencies of ongoing action potential discharge recorded in vivo in cutaneous vasoconstrictor neurons in both animals and humans (15, 20) . To assess the effects of blocking ␣ 1-or ␣2-adrenoceptors with prazosin (10 nM; Sigma) and idazoxan (0.1 M; Sigma), respectively, of blocking P2X1-purinoceptors with NF449 (10 M; Tocris Bioscience, Bristol, UK) or of blocking L-type Ca 2ϩ channels with nifedipine (1 M; Sigma), the arteries were stimulated with trains of 10 stimuli at 1 and 10 Hz and 100 stimuli at 1 Hz, with contractions to these trains of stimuli being measured before and 20 -30 min following the addition of these drugs. In the experiments with idazoxan, prazosin (10 nM) was subsequently added to assess the effects of blocking ␣ 1-and ␣2-adrenoceptors. Similarly, in the experiments with NF449, the combination of prazosin (10 nM) and idazoxan (10 nM) was subsequently added to assess the effects of blocking both P2X1-purinoceptors and ␣-adrenoceptors. One artery segment that was stimulated at the same time points, but had no drugs applied, controlled for time-dependent changes in the electrically evoked contractions.
In the artery segments used to assess the effects of BAY K 8644 (0.1 M; Sigma) on nerve-evoked contractions, responses to 25 stimuli at 0.1, 0.3, 0.5, and 1 Hz were measured before and 15-30 min after the application of this agent. In separate tissues, the effects of idazoxan (0.1 M; Sigma) were assessed in the absence and in the presence of BAY K 8644 (0.1 M), with contractions to 10 stimuli at 1 and 10 Hz, and to 100 stimuli at 1 Hz, being measured before and 20 -30 min after the addition of this antagonist. In these experiments, the ␣1-adrenoceptor antagonist prazosin was subsequently added to assess the effects of blocking all ␣-adrenoceptors.
Chemically evoked contractions. The sensitivity of arteries from sham-operated and SCI rats to the ␣ 1-adrenoceptor agonist PE and to the ␣ 2-adrenoceptor agonist clonidine was assessed either in the absence or in the presence of nifedipine (1 M). In these experiments, cumulative concentration-response curves were first determined for PE (0.01-300 M) and then, after washout, for clonidine (0.001-10 M). For these concentration-response curves, the concentration of agonist was increased by half-log increments, with the tissue exposed to each concentration for 4 min or until the contraction produced had plateaued if this took longer than 4 min.
Data Analysis
The arteries from SCI rats are referred to as SCI arteries, and those from sham-operated rats are referred to as control arteries. The output from the myograph was recorded and analyzed using a PowerLab data acquisition system and the program Chart (ADInstruments, Bella Vista, NSW, Australia). The peak amplitudes of the contractions to the trains of electrical stimuli, PE, and clonidine were measured. Because the amplitude of the nerve-evoked contractions in untreated arteries declined with time during the experiment (Ͻ5%), the changes in the amplitude of contractions produced by nifedipine and by the neurotransmitter antagonists were calculated by comparing the relative changes produced in the drug-treated arteries with those observed at the same time points in untreated arteries. For the contractions evoked by 10 pulses at 10 Hz, the rise time was the time between the response reaching 10% and reaching 90% of its peak amplitude and the decay time was the time between the response dropping from 90 to 10% of its peak amplitude (determined using the peak parameters routine in the program Chart). The EC50s of the concentrationresponse curves for PE and clonidine were estimated by fitting the data to the Hill equation using nonlinear regression analysis (Prism 4; GraphPad Software, San Diego, CA).
All statistical comparisons were made using SPSS 19 (IBM). Before comparison, the data sets were checked for homogeneity of variance using Levene's test. Where there were no differences in variance between the data sets, the data are presented as means Ϯ SE and comparisons were made with Student's paired or unpaired t-tests. Where there was a significant difference in variance between the data sets, the data are presented as median and interquartile range and comparisons were made with Mann-Whitney U-tests for unpaired data or Wilcoxon signed-rank tests for paired data. When multiple pairwise comparisons were made in individual tissues, the P values were adjusted using the false discovery rate procedure (10) . P values Ͻ0.05 were considered to indicate significant differences. Unless otherwise indicated in the text, P values were obtained using unpaired t-tests. In all cases, n indicates the number of animals studied.
RESULTS

Basal Conditions and Endothelium-Dependent Vasodilation
Artery segments from six control (sham-operated) and six SCI rats were studied. The estimated lumen diameter of the artery segments after the normalization procedure (see MATERIALS AND METHODS) was significantly smaller for the SCI arteries (control: 814 Ϯ 27 m; SCI: 727 Ϯ 15 m; P Ͻ 0.05). As a consequence the basal wall tension was larger for control arteries than it was for SCI arteries (3.3 Ϯ 0.1 and 2.7 Ϯ 0.2 mN/mm; P Ͻ 0.05). The difference in vascular dimensions could not be explained by a decrease in postoperative body wt gain as this was significantly greater in SCI rats (control weight gain: 94 Ϯ 9 g; SCI weight gain: 138 Ϯ 5 g; P Ͻ 0.01). These effects of SCI are similar to those we have previously reported for tail arteries from female Wistar rats (43) . In arteries precontracted with PE (3 M), application of carbachol (1 M) produced a similar reduction in active force in both control and SCI arteries (%relaxation: control: 50 Ϯ 6.5%; SCI: 62 Ϯ 3.3%; P ϭ 0.57). The increase in wall tension produced by 3 M PE did not differ between control and SCI arteries (control: 8.1 Ϯ 0.6 mN/mm; SCI: 7.3 Ϯ 1.2 mN/mm; P ϭ 0.56).
SCI Increased Effectiveness of Neurovascular Transmission
Also as previously reported for arteries from female rats, SCI markedly increased the peak amplitude of contractions of tail arteries to 25 pulses at 0.1-1 Hz in male rats (Fig. 1) . The size of this enhancement was most marked at the lowest frequency of stimulation (0.1 Hz increased 5-fold) and was less at higher frequencies of stimulation (1 Hz increased 2-fold). In addition to increasing the amplitude of the contractions, SCI prolonged both the rise time and the decay time of nerveevoked contractions. This effect was most clearly apparent for the contractions to 10 pulses at 10 Hz ( Fig. 2 ; Table 1 ).
SCI Markedly Increased the Contribution of L-Type Ca 2ϩ Channels to Nerve-Mediated Contraction
In control arteries, application of the L-type Ca 2ϩ channel blocker nifedipine (1 M) did not change the peak amplitude of contractions to 10 pulses at 1 and 10 Hz or to 100 pulses at 1 Hz (Fig. 2, A and B) . In contrast, in SCI arteries, nifedipine reduced the peak amplitude of contractions to these trains of stimuli and this effect was most marked for contractions to 100 pulses at 1 Hz, which were reduced by ϳ50% (Fig. 2, A and B) . Nifedipine also reduced both the rise time and decay time of electrically evoked contractions in SCI arteries but not in control arteries ( Fig. 2A ; Table 1 ). In the presence of nifedipine, electrically evoked contractions of the SCI-arteries had a tendency to be larger than those of the control arteries ( Fig. 2A) but this difference did not reach the level of statistical significance (P ϭ 0.06 for contractions to 100 pulses at 1 Hz). However, the rise time and the decay time of the contractions to 10 pulses and 10 Hz were still significantly prolonged in SCI arteries treated with nifedipine (Table 1) . Figure 3 shows the effects of P2X-purinoceptor antagonist NF449 (10 M), the combination of prazosin and idazoxan and the mixture of all three antagonists on the peak amplitude of contractions to 10 pulses at 1 and 10 Hz. The chosen concentration of NF499 completely blocks contractions to 1 M ␣,␤-methylene-ATP (a P2X1-purinoceptor agonist). In both control and SCI arteries, NF449 did not significantly change the contractions, whereas the combination of ␣-adrenoceptor antagonists reduced the contractions to 1 Hz by ϳ85% and to 10 Hz by ϳ70%. In tissues treated with all three antagonists, the blockade was not greater than that produced by the combination of prazosin and idazoxan (Fig. 3, A and B) . The blockades of contractions to 100 pulses at 1 Hz (not shown) produced by these antagonists alone and in combination were similar to those for 10 pulses at 1 Hz. These findings indicate that electrically evoked contractions of both control and SCI tail arteries are primarily mediated by the actions of nerve-released NE at smooth muscle ␣-adrenoceptors (see also Refs. 42, 43) .
SCI Did Not Change the Contributions of NE and ATP to Neurovascular Transmission
SCI Reduced the Contribution of Smooth Muscle ␣ 2 -Adrenoceptors to Neurovascular Transmission
Blockade of ␣ 1 -adrenoceptors with prazosin (10 nM) reduced the peak amplitude of contractions to 10 and 100 pulses at 1 Hz in both control and SCI arteries by Ն80% (see also Refs. 42, 43) . In control arteries, the ␣ 2 -adrenoceptor antagonist idazoxan reduced the peak amplitude of contractions to these trains of stimuli by ϳ40%, but in SCI arteries this agent did not reduce the peak amplitude of these contractions (Fig. 4,  A and B) . However, idazoxan did reduce the sustained contraction measured at the end of the trains of 100 pulses at 1 Hz in both control and SCI arteries ( Fig. 4A ; P Ͻ 0.05, by paired t-test). Furthermore, comparison of the integrals of the contractions to 100 pulses at 1 Hz revealed that the absolute reduction in the area under the curve produced by idazoxan was similar for both control and SCI arteries (control: 93.3 Ϯ 20.3 mN/mm; SCI: 95.6 Ϯ 17.6 mN/mm; P ϭ 0.94).
SCI Did Not Change the Facilitatory Effect of Blocking Prejunctional ␣ 2 -Adrenoceptors
In rat tail artery, blockade of prejunctional ␣ 2 -adrenoceptors with idazoxan has a facilitatory effect on NE release (5). Therefore a possible explanation for the changed effects of idazoxan in SCI arteries is that blockade of prejunctional ␣ 2 -adrenoceptors has a greater facilitatory effect on neurotransmitter release. Because the component of nerve-evoked contraction that is mediated by postjunctional ␣ 2 -adrenoceptors takes several seconds to develop, the peak amplitude of contractions to 10 pulses at 10 Hz is determined primarily by the activation of ␣ 1 -adrenoceptors alone (3, 39) . This explains why idazoxan, via its prejunctional facilitatory action, in- Percent change data are presented as means Ϯ SE. Rise time and decay time data are presented as median and interquartile range (in parentheses). *P Ͻ 0.05, within group differences produced by the application of idazoxan by Wilcoxon signed rank tests. †P Ͻ 0.05, ‡P Ͻ 0.01), differences between control and spinal cord injury (SCI) arteries by Mann-Whitney U tests or unpaired t-tests. and SCI arteries (bottom traces) evoked by 10 pulses at 1 and 10 Hz, and 100 pulses at 1 Hz, before (thin line) and during (thick line) application of nifedipine (1 M). B: peak amplitude of contractions to these trains of stimuli in the presence of nifedipine plotted as a percentage of the predrug contractions in both control arteries (white bars; n ϭ 6) and SCI arteries (black bars; n ϭ 6). Data are presented as medians and interquartile ranges. *P Ͻ 0.05, statistical differences between contractions before and during application of nifedipine in SCI arteries by Wilcoxon signed rank tests.
† P Ͻ 0.01, statistical differences between control and SCI arteries indicated by Mann Whitney U-tests.
creased the amplitude of contractions to 10 pulses at 10 Hz (Fig. 4, A and B) . As the relative size of the idazoxan-induced increase in contraction did not differ between control and SCI arteries (Fig. 4B) , the facilitatory effect of blocking prejunctional ␣ 2 -adrenoceptors was not changed by SCI.
In accord with activation of ␣ 2 -adrenoceptors mediating a slowly developing component of nerve-evoked contraction, in both control and SCI arteries idazoxan did not change the rise time of contractions to 10 pulses at 10 Hz but it did speed their decay time ( Fig. 4A; Table 2 ). However, the percent change in decay time produced by idazoxan was smaller in SCI arteries (Table 2) . Furthermore, in the presence of idazoxan, the decay time in SCI arteries was still about twice as long as in control arteries.
SCI Increased the Contribution of L-Type Ca
2ϩ Channels to ␣ 1 -and ␣ 2 -Adrenoceptor Agonist-Induced Contractions SCI did not change the EC 50 ( Fig. 5B ; P ϭ 0.12) or maximum contraction ( Fig. 5A ; P ϭ 0.32) for the ␣ 1 -adrenoceptor agonist PE. The EC 50 (control: 0.02 Ϯ 0.01 M; SCI: 0.05 Ϯ 0.01; P ϭ 0.08) and the maximum contraction ( Fig. 5C;   Fig. 3 . Nerve-evoked contractions of control and SCI arteries were primarily mediated by the action of norepinephrine at ␣-adrenoceptors. A and B: peak amplitude of contractions to trains of 10 pulses at 1 Hz (A) and 10 Hz (B) in the presence of NF449 (10 M; white bars), prazosin together with idazoxan (10 nM and 0.1 M, respectively; gray bars), and the combination of all 3 antagonists (solid black bars) plotted as a percentage of the predrug contractions in both control arteries (n ϭ 6) and SCI arteries (n ϭ 6). Data are presented as means Ϯ SE. *P Ͻ 0.01, statistical differences between contractions before and during application of the antagonists by paired t-tests. The P2X1-purinoceptor antagonist NF449 did not significantly change the contractions whereas the combination of ␣-adrenoceptor antagonists prazosin and idazoxan markedly reduced the contractions. Blockade produced by the combination of all 3 antagonists was not greater than that produced by ␣-adrenoceptor blockade. Fig. 4 . Blockade of nerve-evoked contractions produced by the ␣2-adrenoceptor antagonist idazoxan (0.1 M) was markedly reduced for stimulation at 1 Hz in SCI arteries. In these experiments, the effects of blocking postjunctional ␣2-adrenoceptors are revealed at 1 Hz and effects of blocking prejunctional ␣2-adrenoceptors are prominent at 10 Hz. A: averaged overlaid traces showing contractions of control arteries (top traces) and SCI arteries (bottom traces) evoked by 10 pulses at 1 Hz and 10 Hz, and 100 pulses at 1 Hz, before (thin line) and during (thick line) application of idazoxan. B: peak amplitude of contractions to these trains of stimuli in the presence of idazoxan plotted as a percentage of the predrug contractions in both control arteries (white bars; n ϭ 6) and SCI arteries (black bars; n ϭ 6). Data are presented as means Ϯ SE. * P Ͻ 0.05, ** P Ͻ 0.01, statistical differences between contractions before and during application of idazoxan by paired t-tests.
† P Ͻ 0.01, statistical differences between control and SCI arteries by unpaired t-tests. While reduction of contractions to trains of pulses at 1 Hz by idazoxan was less after SCI (diminished postjunctional role of ␣2-adrenoceptors), the facilitatory effects of this antagonist on contractions to 10 pulses at 10 Hz were not significantly changed by SCI (no change in the prejunctional role of ␣2-adrenoceptors). P ϭ 0.22) for the ␣ 2 -adrenoceptror agonist clonidine also did not differ significantly between the control and SCI arteries. However, the inhibitory effects of nifedipine (1 M) on reactivity to both PE and clonidine were increased in SCI arteries. In control arteries, nifedipine produced about a twofold increase in EC 50 for PE (Fig. 5B ) but did not significantly change the maximum contraction to this agent (Fig. 5A) . By contrast, in SCI arteries, nifedipine produced about a fivefold increase in EC 50 for PE (Fig. 5B ) and reduced the maximum contraction to this agent by ϳ40% (Fig. 5A) . Clonidine-evoked contractions of control arteries were more sensitive to nifedipine than those to PE, with about a 2.5-fold increase in EC 50 (Ϫnifedipine: 0.02 Ϯ 0.1 M; ϩnifedipine: 0.05 Ϯ 0.1 M; P Ͻ 0.05, by paired t-test) and an ϳ60% reduction in the maximum contraction (Fig. 5C) . In SCI arteries, nifedipine reduced the maximum contraction to clonidine by ϳ90% (Fig. 5C ). Because of the marked inhibitory effect of nifedipine in SCI arteries, it was not possible to determine the EC 50 for clonidine in its presence.
BAY K 8644 Mimics the Effects of SCI on Neurovascular Transmission
Because the findings presented above suggest SCI increases contribution of L-type Ca 2ϩ channels to activation to the vascular muscle, the effects of increasing the activity of these channels with BAY K 8644 were investigated in arteries from uninjured rats. BAY K 8644 (0.1 M; n ϭ 10) did not increase the basal tone of the arteries, but it did produce an increase in the peak amplitude of contractions to 25 pulses at 0.1-1 Hz (Fig. 6 ). This facilitatory effect of BAY K 8644 was not observed in arteries pretreated with nifedipine (1 M; n ϭ 6), confirming that it is mediated by increasing the activity of L-type Ca 2ϩ channels. As with the effects of SCI, the enhancement of neurovascular transmission produced by BAY K 8644 was most marked at the lowest frequency of stimulation (increased 4.5-fold at 0.1 Hz) and declined at higher frequencies of stimulation (increased 2-fold at 1 Hz). Also as observed for SCI arteries, contractions evoked by short trains of stimuli in the presence of BAY K 8644 had prolonged rise times and decay times ( Fig. 7A; Table 3 ).
BAY K8644 Reduced the Contribution of Smooth Muscle ␣ 2 -Adrenoceptors to Neurovascular Transmission
In the absence of BAY K 8644, idazoxan (0.1 M, n ϭ 8) produced similar reductions in the peak amplitude of contractions to 10 and 100 pulses at 1 Hz to those reported above for arteries from sham-operated rats (cf. Figs. 4 and 7) . However, as observed in SCI arteries, idazoxan did not reduce the peak amplitude of contractions evoked by these trains of stimuli in BAY K 8644 treated arteries (Fig. 7, A and B ; n ϭ 8), but it did Control (n ϭ 6) 1.6 Ϯ 0.1
Data are presented as means Ϯ SE. *P Ͻ 0.01, within group differences produced by the application of idazoxan by paired t-test. †P Ͻ 0.01, differences between control and SCI arteries by unpaired t-test. Fig. 5 . In SCI arteries, nifedipine (1 M) had a greater inhibitory effect on reactivity to both ␣1-and ␣2-adrenoceptor agonists. A and B: maximum contractions (A) and EC50s (B) for the ␣1-adrenoceptor agonist phenylephrine in control (n ϭ 6) and SCI (n ϭ 6) arteries both in the absence (white bars or open symbols) and the presence (black bars or closed symbols) of nifedipine. C: maximum contractions to the ␣2-adrenoceptor agonist clonidine in control and SCI arteries both in the absence (white bars) and the presence (black bars) of nifedipine. All data are presented as means Ϯ SE. * P Ͻ 0.05, ** P Ͻ 0.01, differences between measures in the absence and in the presence of nifedipine by paired t-tests. In SCI arteries, nifedipine produced a greater reduction in the maximum contraction to both agonists and also produced a larger increase in the EC50 for phenylephrine (NB: the marked inhibitory of nifedipine on contractions to clonidine in SCI arteries precluded determination of EC50s).
reduce the sustained contraction measured at the end of the trains of 100 pulses at 1 Hz ( Fig. 7A ; P Ͻ 0.05, by paired t-test). Furthermore, the absolute reduction in the integrals of the contractions to 100 pulses at 1 Hz produced by idazoxan was not significantly changed by BAY K 8644 (ϪBAY K: 84 Ϯ 16 mN·mm Ϫ1 ·s Ϫ1 ; ϩBAY K: 120 Ϯ 41 mN·mm Ϫ1 ·s Ϫ1 ; P ϭ 0.16, by paired t-test). Combined blockade of both ␣ 1 -and ␣ 2 -adrenoceptors (with 10 nM prazosin ϩ 0.1 M idazoxan) reduced the peak amplitude of contractions to 10 and 100 pulses at 1 Hz by Ͼ85% in both the absence and the presence of BAY K 8644. In the presence of NF449 (10 M), the facilitatory effect of BAY K 8644 on electrically evoked contractions was not different from that in its absence (P ϭ 0.23), demonstrating that stimulating the activity of L-type Ca 2ϩ channels does not reveal a purinergic component of neurovascular transmission.
BAY K 8644 did not change the facilitatory effect of idazoxan on contractions to 10 pulses at 10 Hz (Fig. 7, A and  B) , indicating that this agent does not change the effects of blocking prejunctional ␣ 2 -adrenoceptors. However, idazoxan accelerated the decay time of contractions to 10 pulses at 10 Hz in the absence of BAY K 8644, but it did not Blockade of nerve-evoked contractions produced by the ␣2-adrenoceptor antagonist idazoxan (0.1 M) was markedly reduced for stimulation at 1 Hz in BAY K 8644 treated arteries. In these experiments, the effects of blocking postjunctional ␣2-adrenoceptors are revealed at 1 Hz and effects of blocking prejunctional ␣2-adrenoceptors are prominent at 10 Hz. A: averaged traces showing contractions of arteries in the absence (top traces) or in the presence (bottom traces) of BAY K 8644 evoked by 10 pulses at 1 Hz and 10 Hz, and 100 pulses at 1 Hz, before (thin line) and during (thick line) application of idazoxan. B: peak amplitude of contractions to these trains of stimuli in the presence of idazoxan, plotted as a percentage of the pre-drug contractions in the absence (white bars, n ϭ 8) or in the presence (black bars, n ϭ 8) of BAY K 8644. Data are presented as means Ϯ SE. * P Ͻ 0.05, ** P Ͻ 0.01, statistical differences between contractions before and following application of idazoxan by paired t-tests.
† † P Ͻ 0.01, statistical differences between arteries in the absence or in the presence of BAY K 8644 paired t-tests. While blockade of the contractions to trains of pulses at 1 Hz by idazoxan was reduced by BAY K 8644 (diminished postjunctional role of ␣2-adrenoceptors), the facilitatory effects of this antagonist on contractions to 10 pulses at 10 Hz were not significantly changed by BAY K 8644 (no change in the prejunctional role of ␣2-adrenoceptors).
change their time course in the presence of this agent ( Fig.  7A ; Table 3 ).
DISCUSSION
This study demonstrates that a markedly increased contribution of L-type Ca 2ϩ channels to nerve-evoked contraction largely accounts for the enhancement of neurovascular transmission in the tail artery produced by chronic SCI. This change was accompanied by an increase in the contribution of L-type Ca 2ϩ channels to both ␣ 1 -and ␣ 2 -adrenoceptor agonist-induced contractions in SCI arteries. However, the relative contribution of postjunctional ␣ 2 -adrenoceptors to nerve-evoked contractions was greatly reduced by SCI. Instead the nifedipinesensitive component of contraction in SCI arteries appears to be selectively triggered by activation of ␣ 1 -adrenoceptors. This study also demonstrates that acutely increasing the activity of vascular muscle L-type Ca 2ϩ channels with BAY K 8644 mimics the effects of SCI on neurovascular transmission.
The increased effectiveness of neurovascular transmission in the tail artery after SCI that was observed in the present study was similar to that previously reported in female Wistar rats (43) . Thus the enhancement of transmission produced by SCI is not dependent on gender or on the strain of rat studied. Some differences were observed between these studies, however. In females, the magnitude of the enhancement of neurovascular transmission was larger than that observed in the present study, with contractions to trains at 0.1 Hz being increased by Ͼ25-fold both 2 and 8 wk following SCI. Sensitivity to clonidine was increased in arteries from female SCI rats, but the significance of this observation is questionable because, as observed in the present study, the contribution of postjunctional ␣ 2 -adrenoceptors to neurovascular transmission (as revealed by the blockade produced by idazoxan) was markedly reduced. In arteries from both males and females, no changes in sensitivity to PE were observed 6 -8 wk post-SCI. Therefore, it seems likely that similar mechanisms contribute to the SCI-induced increase in neurovascular transmission in both males and females.
In control tail artery, it has previously been reported that contractions evoked by short trains of stimuli are not changed by blockade of L-type Ca 2ϩ channels with nifedipine but that contractions evoked by prolonged activation of the sympathetic nerves are reduced by this agent (4, 36) . In the present study, the nerve-evoked contractions of control arteries were not significantly reduced by nifedipine, but there was a tendency for the contractions measured at the end of trains of 100 pulses at 1 Hz to be reduced by this agent (see Fig. 2A ). By contrast, in SCI arteries, nifedipine reduced all nerve-evoked contractions but its inhibitory effects were most marked for contractions to 100 pulses at 1 Hz (see Fig. 2, A and B) . As the blockade of nerve-evoked contractions produced by ␣ 2 -adrenoceptors was markedly reduced by SCI, but combined blockade of ␣ 1 -and ␣ 2 -adrenoceptors in both control and SCI arteries reduced the contractions by Ͼ85%, it appears that the component of contraction that is sensitive to nifedipine in SCI arteries is produced by activation of ␣ 1 -adrenoceptors.
As previously reported (42), nerve-evoked contractions of tail arteries were not reduced in amplitude by blockade of P2X1-purinoceptors, indicating that under the conditions of the experiment ATP does not contribute significantly to neural activation of the vascular muscle. The concentrations of prazosin and idazoxan used in this study were ϳ10 times higher than the pA 2 values for these agents at ␣ 1 -and ␣ 2 -adrenoceptors, respectively (12, 22) and were chosen to assure their selectivity for these receptors (9, 38) . We (42, 43) have previously reported that, in the presence of both prazosin and idazoxan at these concentrations, contractions evoked by 100 pulses at 1-Hz stimuli were further reduced (total blockade ϳ95%) by a relatively high concentration of the nonselective ␣-adrenoceptor antagonist phentolamine (1 M). These findings indicate that selective concentrations of prazosin plus idazoxan leave a small component of ␣-transmission intact and confirm that NE is the predominant neurotransmitter at sympathetic neurovascular junctions in the rat tail artery.
SCI not only increased the amplitude of nerve-evoked constrictions but also prolonged their time course. In control arteries, idazoxan accelerated the decay of the nerve-evoked contractions but nifedipine had no effect on their time course. Our interpretation of this idazoxan effect is that it reduces a component of neurally evoked contraction that is slow to decay (see also Ref. 3) and that this does not depend on activation of L-type Ca 2ϩ channels. Both idazoxan and nifedipine reduced the decay time in SCI arteries but the relative acceleration produced by blockade of ␣ 2 -adrenoceptors was smaller than in control arteries (see Table 2 ). These findings also indicate that the contribution of postjunctional ␣ 2 -adrenoceptors to neurovascular transmission is smaller in SCI arteries and that a nifedipine-sensitive component of contraction contributes to prolonging the decay of the contractions in these vessels.
In control arteries, blockade of L-type Ca 2ϩ channels produced only a small rightward shift in the EC 50 for PE and did not change the maximum contraction to this agent. These findings indicate that these ion channels normally play a minor role in ␣ 1 -adrenoceptor-mediated activation of the vascular smooth muscle (see also Ref. 1). However, in arteries from SCI rats, nifedipine more markedly increased the EC 50 and, in addition, reduced the maximum contraction to PE, consistent channels. Accordingly, in control arteries, the maximum contraction to clonidine was substantially reduced by nifedipine and this effect of blocking L-type Ca 2ϩ channels was increased in SCI arteries. Surprisingly, in control arteries, while blockade of ␣ 2 -adrenoceptors reduced the size of contractions to trains of stimuli at 1 Hz by ϳ50%, nifedipine did not reduce these contractions. Thus it appears that L-type Ca 2ϩ channels do not normally contribute to the ␣ 2 -adrenoceptor antagonist-sensitive component of nerve-evoked contraction. Because the blockade of nerve-evoked contraction produced by the combination of idazoxan and prazosin in control arteries is not greater than that produced by prazosin alone, it has been suggested that activation of ␣ 2 -adrenoceptors by neurally released NE has a synergistic action on ␣ 1 -adrenoceptor-mediated contractions (42, 43) . In tail artery, a synergistic action of exogenously applied ␣ 2 -adrenocepter agonists on contractions to ␣ 1 -adrenoceptor agonists has been reported, but this effect depends on influx of extracellular Ca 2ϩ through L-type Ca 2ϩ channels (41) . Together these findings suggest that nervereleased NE acts at a discrete population of ␣ 2 -adrenoceptors that do not require L-type Ca 2ϩ channel activation to evoke contraction. The findings for clonidine demonstrated a substantial reduction in the nifedipine-resistant component of ␣ 2 -adrenoceptor-mediated contraction in SCI arteries (Fig. 5C) , and this perhaps explains the reduced contribution of ␣ 2 -adrenoceptors to nerve-evoked contractions.
To investigate the effects of increasing the activity of L-type Ca 2ϩ channels on nerve-evoked contractions, we assessed the effects of the L-type Ca 2ϩ channel agonist BAY K 8644. At the concentration used (0.1 M), BAY K 8644 has been demonstrated to produce a large increase in the L-type Ca 2ϩ current in freshly isolated myocytes from the rat tail artery (31) . Like SCI, BAY K 8344 markedly increased the size of nerve-evoked contractions and this effect was most marked at the lowest frequency of stimulation studied. Furthermore, this facilitatory effect on neurovascular transmission was associated with marked decrease in the contribution of postjunctional ␣ 2 -adrenoceptors to nerve-evoked contraction. These effects of BAY K 8644 are very similar to those produced by SCI. Because nifedipine prevented effects of BAY K 8644 on neurovascular transmission, they are almost certainly due to an increased activity of L-type Ca 2ϩ channels. At present, we do not know if the effects of SCI are produced by a change in the gating of L-type Ca 2ϩ channels and/or a change in their expression. However, our findings in SCI arteries do suggest changes in channel coupling to the postjunctional adrenoceptors activated by neurally released NE. Testing these hypotheses will require detailed correlated electrophysiological, biochemical, and pharmacological analysis.
Axon reflex-mediated vasodilation is reduced in individuals with SCI (18) . One possible explanation is that spinal reflex activation of sympathetic vasoconstrictor axons coupled with hyperreactivity of the cutaneous arterial vessels to neurally released and circulating vasoconstrictor agents opposes the vasodilation produced by sensory neuropeptides released by activation of the peptidergic primary afferent fibers (18, 37) . In addition, the increase in skin blood flow that follows removal of an externally applied pressure stimulus is also reduced in SCI individuals (32) and this may, at least in part, be explained by increased arterial vasoconstriction (37) . These changes may contribute to the etiology of pressure sores (32) and contribute to slowing of skin wound repair in SCI patients (26) . Therefore, it is possible that the changes in vascular muscle function observed in the present study contribute to increasing the risk of pressure sores in SCI individuals.
While arterial vessels supplying skin of the hands and feet show little or no vasoconstriction in response to a postural challenge, experiments in uninjured humans indicate that neural regulation of skin blood flow elsewhere contributes significantly to baroreflex control of peripheral resistance (see Refs. 28, 29) . Therefore loss of baroreflex control of cutaneous vasoconstrictor neurons is likely to contribute to postural hypotension in SCI patients. Following cervical or thoracic SCI, sensory stimuli such as bladder percussion applied below the level of the lesion evoke concurrent activation of both cutaneous and muscle vasoconstrictor neurons supplying the lower limbs (34) , leading to a decrease in blood flow (13, 34) . The magnitude of this sensory stimulus-evoked reduction in lower limb blood flow is similar with lesions below and above T6 (13) , but only with lesions above this level do these sensory stimuli produce significant increases in blood pressure [autonomic dysreflexia (AD)]. This hypertensive effect with lesions above T6 is usually explained by severing of bulbospinal connections to the preganglionic neurons controlling splanchnic arterial vessels and as a consequence spinal reflex activation produces marked vasoconstriction in this large vascular bed (21) . However, loss of baroreflex regulation of splanchnic vasoconstrictor neurons also means that regulation of blood flow in this vascular bed is unable to compensate for changes in vascular resistance elsewhere in the body (see Ref. 28) . In rats, AD is observed with lesions above T5 that sever bulbospinal connections to splanchnic vasoconstrictor neurons in this species (17) . Blood flow in skin of the tail is markedly reduced during AD evoked by colorectal distension in rats with spinal cord transection at T4 (19) . Taken together these observations indicate that vasoconstriction in the cutaneous vascular bed is likely to contribute to the marked increase in peripheral resistance that underlies the elevation of blood pressure during AD, but this contribution may be masked when baroreceptor control of the splanchnic vasculature is intact.
Rapidly absorbed nifedipine medications have been the most widely used hypotensive agents for the acute management of AD (16) , but in recent years their use has declined because of the potential for serious side-effects, such as stroke and myocardial infarction. However, there have been no reports of serious adverse effects for nifedipine used in the management of AD in patients with SCI. Indeed, if an increased contribution of L-type Ca 2ϩ channels to neurovascular transmission is the primary mechanism that increases neurovascular transmission in arterial vessels following SCI, it may be that drugs that block these channels are particularly effective for treatment of AD because they interfere with one of the mechanisms that amplify spinal-reflex evoked vasoconstriction.
In summary, this study demonstrates that SCI changes the mechanisms whereby nerve-released NE activates vascular smooth muscle in the rat tail artery, with a large increase in the contribution of L-type Ca 2ϩ channels to nerve-evoked contrac-tions. These changes are likely to contribute to modifying neural control of skin blood flow in individuals with SCI (34, 37) . In addition, the findings perhaps explain why nifedipine has proved useful in the pharmacological management of AD. However, it remains to be demonstrated that L-type Ca 2ϩ channels contribute to the enhancement of neurovascular transmission in other vascular beds following SCI.
